Directory

>

Maxim Soloviev Md Dsp

avatar

Maxim Soloviev Md Dsp

Executive Director, Toxicology | Incyte

Wilmington, Delaware, United States

View contact details (it's free)

Maxim Soloviev Md Dsp

Summary

Dr. Maxim Soloviev is an accomplished executive in the field of toxicology, currently serving as the Executive Director at Incyte, where he leads preclinical and clinical development initiatives. With a robust background in pharmacology and drug development, he has extensive experience in managing toxicology studies and authoring regulatory submissions. Dr. Soloviev's expertise encompasses a wide range of areas including clinical research, assay development, and translational medicine. He has held various leadership roles within Incyte, contributing significantly to the company's advancements in biological products. His academic credentials include a PhD in Surgery, Cardiology, and Metabolic Diseases, underscoring his deep understanding of complex medical and scientific principles. Dr. Soloviev is recognized for his ability to translate scientific data into actionable insights, making him a valuable asset in the pharmaceutical industry. His dedication to research and development continues to drive innovation in toxicology and safety pharmacology. In addition to his professional achievements, his international background adds a unique perspective to his work.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Immigrant

Professional interests

Industry-specific interests

Emerging Technologies

Leadership Development

Organisational experience

Corporate Experience

Maxim Soloviev Md Dsp

Work Experience

company logo

Executive Director, Toxicology at

Incyte

February 2024 - Present

company logo

Senior Director, Toxicology at

Incyte

August 2018 - February 2024

company logo

Director, Toxicology at

Incyte

August 2013 - August 2018

company logo

Associate Director at

Incyte

September 2006 - July 2013

company logo

Study Director at

WIL Research

March 2002 - September 2006

company logo

Scientist at

Jefferson University Physicians

January 2000 - January 2001

company logo

Reserch Fellow at

Cleveland Clinic

January 1995 - January 2000

Logos provided by Logo.dev

Maxim Soloviev Md Dsp

Education

Pavlov Medical University of St. Petersburg, Phd

January 1989 - January 1992

Pavlov Medical University of St. Petersburg, Md

January 1981 - January 1987

Frequently Asked Questions about Maxim Soloviev Md Dsp

What is Maxim Soloviev Md Dsp email address?

Maxim Soloviev Md Dsp's primary email address is **************@jefferson.edu. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Maxim Soloviev Md Dsp work for?

Maxim Soloviev Md Dsp is a Executive Director, Toxicology at Incyte, a company specializing in Biological products, except diagnostic.

Where Maxim Soloviev Md Dsp graduated from?

Maxim Soloviev Md Dsp holds a degree in Surgery, Cardiology, And Metabolic Diseases from Pavlov Medical University of St. Petersburg.

How can I directly contact Maxim Soloviev Md Dsp?

To contact Maxim Soloviev Md Dsp directly, you can use the email address **************@jefferson.edu. Complete contact information is available upon registration with Muraena.

Is Maxim Soloviev Md Dsp an immigrant?

Yes, Maxim Soloviev Md Dsp is an immigrant and currently based in United States

Who is Maxim Soloviev Md Dsp?

Dr. Maxim Soloviev is an accomplished executive in the field of toxicology, currently serving as the Executive Director at Incyte, where he leads preclinical and clinical development initiatives. With a robust background in pharmacology and drug development, he has extensive experience in managing toxicology studies and authoring regulatory submissions. Dr. Soloviev's expertise encompasses a wide range of areas including clinical research, assay development, and translational medicine. He has held various leadership roles within Incyte, contributing significantly to the company's advancements in biological products. His academic credentials include a PhD in Surgery, Cardiology, and Metabolic Diseases, underscoring his deep understanding of complex medical and scientific principles. Dr. Soloviev is recognized for his ability to translate scientific data into actionable insights, making him a valuable asset in the pharmaceutical industry. His dedication to research and development continues to drive innovation in toxicology and safety pharmacology. In addition to his professional achievements, his international background adds a unique perspective to his work.

Maxim`s contact details

mail

**************@jefferson.edu

**********@usa.net

*********@incyte.com

Colleagues

Ryan Mcgeehan

Vice President, Head of Project Management

Scott Larsen

Vice President, IP

avatar
Scott Muir

Executive Director - Head of ROW Markets (REALM)

Oliver Manzke

Associate Vice President, Global Program Head

avatar
Olivera Ventresca

Executive Director, Strategy & Operational Excellence

avatar
Onofrio Mastandrea

Regional Vice President, General Manager

avatar
Pablo Cagnoni

President and Head of R&D

avatar
Pamela Politis

Associate Vice President, North American Legal

avatar
Patrick Mayes

Group Vice President, Head of Biology

View Contact details (it's free)
Request Profile Removal